Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

TMO vs ABT

Thermo Fisher Scientific Inc. and Abbott Laboratories compared side by side. Customize this comparison

Performance (normalized)

-31%-16%-1%+14%+29%stockmarketcap.io

Key metrics

MetricTMO logoTMOABT logoABT
Price$523.44$95.39
Market cap$194.52B$166.15B
P/E ratio (TTM)27.52x25.19x
P/S ratio (TTM)4.12x3.50x
Dividend yield0.36%2.69%
Beta0.870.62
1-year return+22.37%-28.86%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.